Comparative dose-dependence study of FK506 on transected mouse sciatic nerve repaired by allograft or xenograft

Journal of the Peripheral Nervous System

Volumn 8, Issue 3, 2003, Pages 145-154

  Udina, Esther ^a   Voda, Jan ^b   Gold, Bruce G ^b   Navarro, Xavier ^a,c  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Allograft; FK506; Immunosuppression; Nerve regeneration; Sciatic nerve; Xenograft

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BREEDING; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ELECTRON MICROSCOPY; FEMALE; GRAFT REJECTION; INFLAMMATORY CELL; MICROSCOPY; MOUSE; MYELINATED NERVE; NERVE FIBER REGENERATION; NERVE GRAFT; NERVE TRANSECTION; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; XENOGRAFT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED STRAINS; MICROSCOPY, ELECTRON; NERVE FIBERS, MYELINATED; NERVE REGENERATION; SCIATIC NERVE; TACROLIMUS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0042191634     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8027.2003.03020.x     Document Type: Article

References (67)

1. Aguayo AJ, Bray GM, Perkis CS, Duncan ID (1979). Axon-sheath cell interactions in peripheral and central nervous system transplants. Soc Neurosci Symp 4:361-383.
2. Andersson J, Nagy S, Groth CG, Andersson U (1992). Effects of FK506 and cyclosporin A on cytokine production: studies in vitro at a single-cell level. Immunology 75:136-142.
3. Bain JR (1998). Peripheral nerve allografting: Review of the literature with relevance to composite tissue transplantation. Transplant Proc 30:2762-2767.
4. Bain JR (2000). Peripheral nerve and neuromuscular allotransplantation: current status. Microsurgery 20:384-388.
5. Bain JR, Mackinnon SE, Hudson AR, Faik RE, Falk JA, Hunter DA (1988). The peripheral nerve allograft. An assessment of regeneration across nerve allografts in rats immunosuppressed with cyclosporin A. Plast Reconstr Surg 82:1052-1066.
6. Bain JR, Mackinnon SE, Hudson AR, Wade J, Evans P, Makino A, Hunter D (1992). The peripheral nerve allograft in the primate immunosuppressed with cyclosporin A. Histological and electrophysiologic assessment. Plast Reconstr Surg 90:1035-1046.
7. Beuche W, Friede RL (1984). The role of non-resident cells in Wallerian degeneration. J Neurocytol 13:767-796.
8. Bisby MA, Chen S (1990). Delayed Wallerian degeneration in sciatic nerves of C57BL/Ola mice is associated with impaired regeneration of sensory axons. Brain Res 15:117-120.
9. Büttemeyer R, Rao U, Jones NF (1995). Peripheral nerve allograft transplantation with FK506: functional, histological and immunological results before and after discontinuation of immunosuppression. Ann Plast Surg 35:396-401.
10. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH (1993). Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 90:9808-9812.
11. Dubernard J-M, Owen E, Herzberg G, Lanzetta M, Martin X, Kapila H, Dawahra M, Hakim NS (1999). Human hand allograft: report on first 6 months. Lancet 353:1315-1320.
12. Evans PJ, Midha R, Mackinnon SE (1994). The peripheral nerve allograft: a comprehensive review of regeneration and neuroimmunology. Prog Neurobiol 43:187-233.
13. Feng FY, Ogden MA, Myckatyn TM, Grand AG, Jensen JN, Hunter DA, Mackinnon SE (2001). FK506 rescues peripheral nerve allografts in acute rejection. J Neurotrauma 18:217-229.
14. Fu SY, Gordon T (1997). The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14:67-116.
15. Giannini C, Lais AC, Dyck PJ (1989). Number, size, and class of peripheral nerve fibers regenerating after crush, multiple crush, and graft. Brain Res 500:131-138.
16. Gold BG (2000). Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. Expert Opin Investig Drugs 10:2331-2342.
17. Gold BG, Densmore V, Shou W, Matzuk MM, Gordon HS (1999). Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neuroprotective action of FK506. J Pharmacol Exp Ther 289:1202-1210.
18. Gold BG, Katoh K, Storm-Dickerson T (1995). The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci 15:7509-7516.
19. Gold BG, Storm-Dickerson T, Austin DR (1994). The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor Neurol Neurosci 6:287-296.
20. Gold BG, Zeleny-Pooley M, Wang MS, Chaturvedi P, Armistead DM (1997). A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp Neurol 147:269-278.
21. Gómez N, Cuadras J, Butí M, Navarro X (1996). Histologic assessment of sciatic nerve regeneration following resection and graft or tube repair in the mouse. Restor Neurol Neurosci 10:187-196.
22. Grand AG, Myckatyn TM, Mackinnon SE, Hunter DA (2002). Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J Neurosurg 96:924-932.
23. Gulati AK (1988). Evaluation of acellular and cellular nerve graft in repair of rat peripheral nerve. J Neurosurg 68:117-123.
24. Guo X, Dillman JF, Dawson VL, Dawson TM (2001). Neuroimmunophilins. Novel neuroprotective and neuroregenerative targets. Ann Neurol 50:6-16.
25. Gutmann E, Sanders FK (1943). Recovery of fibre numbers and diameters in the regeneration of peripheral nerves. J Physiol 101:489-518.
26. Hebebrand D, Zohman G, Jones NF (1997). Nerve xenograft transplantation. Immunosuppression with FK-506 and RS-61443. J Hand Surg [Br] 22:304-307.
27. Ide C, Tohyama K, Yokota R, Nitatori T, Onodera S (1983). Schwann cell basal lamina and nerve regeneration. Brain Res 288:61-75.
28. Ishida O, Daves J, Tsai T, Breidenbach WC, Firrell J (1993a). Regeneration following rejection of peripheral nerve allografts of rats on withdrawal of cyclosporine. Plast Reconstr Surg 92:915-926.
29. Ishida O, Martin A, Firrell JC (1993b). Origin of Schwann cells in peripheral nerve allografts in the rat after withdrawal of cyclosporine. J Reconstr Microsurg 9:234-236.
30. Janeway ChA, Travers P, Walfort M, Capra JD (1999). Immunobiology: The Immune System in Health and Disease, 4th Ed. New York Current Biology Publications, New York.
31. Jones JW, Gruber SA, Barker JH, Breidenbach WC (2000). Successful hand transplantation. One-year follow-up. N Engl J Med 343:468-473.
32. Keicho N, Sawado S, Kitamura K, Yotsumoto H, Takaku F (1991). Effects of an immunosuppressor, FK506, on IL-1 production by human macrophages and a macrophage-like cell line, U937. Cell Immunol 132:285-294.
33. Lassner F, Schaller E, Strinhoff G, Wonigrit K, Walter GF, Berger A (1989). Cellular mechanisms of rejection and regeneration in peripheral nerve allografts. Transplantation 48:386-392.
34. Lundborg G (2000). A 25-year perspective of peripheral nerve surgery: evolving neuroscientific concepts and clinical significance. J Hand Surg 25A:329-431.
35. Lyons WE, George EB, Dawson TM, Steiner JP, Snyder SH (1994). Immunosuppressant FK506 promotes neurite out-growth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci USA 91:3191-3195.
36. Mackinnon SE, Hudson AR, Bain JR, Falk RE, Hunter DA (1987). The peripheral nerve allograft: An assessment of regeneration in the immunosuppressed host. Plast Reconstr Surg 79:436-446.
37. Mackinnon SE, Midha R, Bain J, Hunter D, Wade J (1992). An assessment of regeneration across peripheral nerve allografts in rats receiving short courses of cyclosporin A immunosuppression. Neuroscience 46:583-593.
38. Margreiter R, Brandacher G, Ninkovic M, Steurer W, Kreczy A, Schneeberger S (2002). A double-hand transplant can be worth the effort! Transplantation 74:85-90.
39. Midha R, Evans PJ, Mackinnon SE, Wade JA (1993b). Temporary immunosuppression for peripheral nerve allografts. Transplant Proc 25:532-536.
40. Midha R, Mackinnon SE, Becker LE (1994). The fate of Schwann cells in peripheral nerve allografts. J Neuropathol Exp Neurol 53:316-322.
41. Midha R, Mackinnon SE, Evans PJ, Best TJ, Hare GMT, Hunter DA, Falk-Wade JA (1993a). Comparison of regeneration across nerve allografts with temporary or continuous cyclosporin A immunosuppression. J Neurosurg 78:90-100.
42. Myckatyn TM, Ramsey AE, Grand AG, Sen SK, Lowe JB, Hunter DA, Mackinnon SE (2002). The effects of rapamycin in murine peripheral nerve isografts and allografts. Plast Reconstr Surg 109:2405-2417.
43. Navarro X, Butí M, Verdú E (1994). Autotomy prevention by amitriptyline after peripheral nerve section in different strains of mice. Restor Neurol Neurosci 6:151-157.
44. Okajima S, Hojo T, Tamai K, Takai S, Hirasawa Y (2002). Histological and electrophysiological analysis of the peripheral nerve allografts using an immunosuppressive agent. Microsc Res Tech 58:52-58.
45. Osawa T, Ide C, Tohyama K (1987). Nerve regeneration through cryo-treated xenogeneic nerve grafts. Arch Histol Jpn 50:193-208.
46. Perry VH, Brown MC (1992). Role of macrophages in peripheral nerve degeneration and repair. BioEssays 14:401-406.
47. Perry VH, Brown MC, Lunn ER, Tree P, Gordon S (1990). Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve. Eur J Neurosci 2:802-808.
48. Pollard JD, Fitzpatrick L (1973a). An ultrastructural comparison of peripheral nerve allografts and autografts. Acta Neuropathol (Berl) 23:152-165.
49. Pollard JD, Fitzpatrick L (1973b). A comparison of the effects of irradiation and immunosuppressive agents on regeneration through peripheral nerve allografts: an ultrastructural study. Acta Neuropathol (Berl) 23:166-180.
50. Pollard JD, McLeod JG, Gye RS (1973). Regeneration through peripheral nerve allografts. Arch Neurol 28:31-37.
51. Popovic M, Bresjanac M, Sketelj J (1994). Regenerating axons enhance differentiation of perineurial-like cells involved in minifascicle formation in the injured peripheral nerve. J Neuropathol Exp Neurol 53:590-597.
52. Rodríguez FJ, Verdú E, Ceballos D, Navarro X (2000). Neural guides seeded with autologous Schwann cells improve nerve regeneration. Exp Neurol 161:571-584.
53. Sakai K, Date I, Yoshimoto Y, Airsawa T, Nakashima H, Furuta T, Asari S, Ohmoto T (1991). The effect of a new immunosuppressive agent, FK506, on xenogenic neural transplant in rodents. Brain Res 565:167-170.
54. Schreiber SL (1991). Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251:283-287.
55. Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE (1990). The side effects of FK506 in humans. Transplant Proc 22:35-36.
56. Sharkey J, Butcher SP (1994). Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia. Nature 371:336-338.
57. Steiner JP, Connolly MA, Valentine HL, Hamilton GS, Dawson TM, Hester L, Snyder SH (1997a). Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat Med 3:421-428.
58. Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo H, Connolly MA, Liang S, Ramsey C, Li JH, Huang W, Howorth P, Soni R, Fuller M, Sauer H, Nowotnik AC, Suzdak PD (1997b). Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci USA 94:2019-2024.
59. Strasberg SR, Mackinnon SE, Genden EM, Bain JR, Purcell CM, Hunter DA, Hay JB (1996). Long segment nerve allograft regeneration in the sheep model: experimental study and review of the literature. J Reconstr Microsurg 12:529-537.
60. Udina E, Ceballos D, Verdú E, Gold BG, Navarro X (2002). Bimodal dose-dependence study of FK506 on the rate of axonal regeneration in mouse peripheral nerve. Muscle Nerve 26:348-355.
61. Verdú E, Navarro X (1998). The Role of Schwann Cell in Nerve Regeneration. In: Understanding Glial Cells. Castellano B, González B, Nieto-Sampedro M (Eds). Kluwer Academic Publications, Boston, pp 319-359.
62. Wang MS, Zeleny-Pooley M, Gold BG (1997). Comparative dose dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J Pharmacol Exp Ther 282:1084-1097.
63. Yu LT, England J, Hickey WF, Sumner A, Rhee E, Rostami A, Larossa D (1989). Survival and function of peripheral nerve allografts after cessation of long term cyclosporin immunosuppression in rats. Transplant Proc 21:3178-3180.
64. Yu LT, England J, Sumner A, Larossa D, Hickey WF (1990). Electrophysiologic evaluation of peripheral nerve regeneration through allografts immunosuppressed with cyclosporin. J Reconstr Microsurg 6:318-323.
65. Zalewski AA, Gulati AK (1981). Rejection of nerve allografts after cessation of immunosuppression with cyclosporin A. Transplantation 31:88-89.
66. Zalewski AA, Gulati AK (1984a). Failure or cyclosporin A to induce immunological unresponsiveness to nerve allografts. Exp Neurol 23:659-663.
67. Zalewski AA, Gulati AK (1984b). Survival of nerve allografts in sensitized rats treated with cyclosporin A. J Neurosurg 60:828-834.